The role of economic evaluation in mental health care

References

• Porter R. The greatest benefit to mankind, a medical history of mankind. Norton, New York 1997
   Google Scholar
• Knapp M. Economic evaluations and interventions for children and adolescents with mental health problems. Journal of Child Psychology and Psychiatry 1997; 38: 3–25
   PubMed Web of Science ®Google Scholar
• Fein R. Economics of mental health. Basic, New York 1958
   Google Scholar
• McGuire T. Measuring the economic costs of schizophrenia. Schizophrenia Bulletin 1991; 17: 375–388
   PubMed Web of Science ®Google Scholar
• Wills P, Armstrong B, Bradshaw R, et al. The virtuous cycle: working together for health and medical research. Commonwealth of Australia, Canberra 1998
   Google Scholar
• Ragg M. According to the script, we're sick. Age 1999; 4, 7 September
   Google Scholar
• Johnstone P, Zolese G. Systematic review of the effectiveness of planned short hospital stays for mental health care. British Medical Journal 1999; 318: 1387–1390
   PubMed Web of Science ®Google Scholar
• Taylor D, Aitchison K. The pharmaco-economics of atypical antipsychotics. International Journal of Psychiatry in Clinical Practice 1999; 3: 237–248
   PubMedGoogle Scholar
• McCrone P, Weich S. Mental health care costs: paucity of measurement. Social Psychiatry and Psychiatric Epidemiology 1996; 31: 70–77
   PubMed Web of Science ®Google Scholar
• Evers S V, Vijk A, Ament A. Economic evaluation of mental health care interventions: a review. Health Economics 1997; 6: 161–177
   PubMed Web of Science ®Google Scholar
• Drummond M, O'Brien B, Stoddart G, Torrance G. Methods for the economic evaluation of health care programmes2nd edn. Oxford University Press, Oxford 1998
   Google Scholar
• Hunter C, McFarlane A. DRGs Australian psychiatry. Australian and New Zealand Journal of Psychiatry 1994; 28: 114–120
   PubMed Web of Science ®Google Scholar
• Panzarino P. The costs of depression: direct and indirect; treatment versus nontreatment. Journal of Clinical Psychiatry 1998; 59: 11–14
   PubMed Web of Science ®Google Scholar
• Manning W. Panel on cost-effectiveness in health and medicine recommendations: identifying costs. Journal of Clinical Psychiatry 1999; 60: 54–58
   PubMed Web of Science ®Google Scholar
• Rosenheck R, Cramer J, Allan E, et al. Cost-effectiveness of clozapine in patients with high and low levels of hospital use. Archives of General Psychiatry 1999; 57: 565–572
   Web of Science ®Google Scholar
• Johnston S, Salkeld G, Sanderson K, Issakidis C, Teesson M, Buhrich N. Intensive case management: a cost-effectiveness analysis. Australian and New Zealand Journal of Psychiatry 1998; 32: 551–559
   PubMed Web of Science ®Google Scholar
• Hafner H, Heiden W. The evaluation of mental heath care systems. British Journal of Psychiatry 1989; 155: 12–17
   PubMed Web of Science ®Google Scholar
• Wolff N, Helminiak T, Tebes J. Getting the cost right in cost-effectiveness analyses. American Journal of Psychiatry 1997; 154: 736–743
   PubMed Web of Science ®Google Scholar
• Hawthorne G, Herrman H, Thomas R. The validity of self-report health-related quality of life among those suffering mental illness. Journal of Mental Health Policy and Economics 2000; 3(Suppl. 1)S10
   Google Scholar
• Mihalopoulos C, McGorry P, Carter R. Is phase-specific, community-oriented treatment of early psychosis an economically viable method of improving outcome?. Acta Psychiatrica Scandinavica 1999; 54: 1–9
   Google Scholar
• Wood J, Taylor S, Lichtman R. Social comparison in adjustment to breast cancer. Journal of Personality and Social Psychology 1985; 49: 1169–1183
   PubMed Web of Science ®Google Scholar
• Diener E, Suh E. Age and subjective wellbeing: an international analysis. Annual Review of Gerontology and Geriatrics 1998; 17: 304–324
   Google Scholar
• Larsen R. Neuroticism and selective encoding and recall of symptoms: evidence from a combined concurrent-retrospective study. Journal of Personality and Social Psychology 1992; 62: 489–488
   Web of Science ®Google Scholar
• Hooker K, Siegler I. Separating apples from oranges in health ratings: perceived health includes psychological well-being. Behaviour, Health and Aging 1992; 2: 81–92
   Google Scholar
• Headey B, Veenhoven R, Wearing A. Top-down versus bottomup theories of subjective wellbeing. Social Indicators Research 1991; 24: 81–100
   Web of Science ®Google Scholar
• Diener E, Sandvik E, Deidlitz L, Diener M. The relationship between income and subjective well-being: relative or absolute?. Social Indicators Research 1993; 28: 195–223
   Web of Science ®Google Scholar
• Tait M, Padgett M, Baldwin T. Job satisfaction and life satisfaction: a re-examination of the strength of the relationship and gender effects as a function of the date of the study. Journal of Applied Psychology 1989; 74: 502–507
   Web of Science ®Google Scholar
• Gartner J, Larson D, Allen G. Religious commitment and mental health: a review of the empirical literature. Journal of Psychology and Religion 1991; 19: 6–25
   Google Scholar
• Diener E, Suh E, Lucas R, Smith H. Subjective well-being: three decades of progress. Psychological Bulletin in press
   Web of Science ®Google Scholar
• Kring A, Kerr S, Smith D, Neale J. Flat affect in schizophrenia does not reflect diminished subjective experience of emotion. Journal of Abnormal Psychology 1993; 102: 507–517
   PubMed Web of Science ®Google Scholar
• Jenkins C. Assessment of outcomes of health intervention. Social Science and Medicine 1992; 35: 367–375
   PubMed Web of Science ®Google Scholar
• Awad G, Hogan T, Voruganti L, Heslegrave R. Patients' subjective experiences on antipsychotic medications: implications for outcome and quality of life. International Clinical Psychopharmacology 1995; 10S: 132
   Google Scholar
• Epstein A, Hall J, Tognetti J, Son L, Conant L. Using proxies to evaluate quality of life: can they provide valid information about patients' health status and satisfaction with medical care?. Medical Care 1989; 27(Suppl.)S19–S98
   Google Scholar
• Voruganti L, Heslegrave R, Awad A, Seeman M. Quality of life measurement in schizophrenia: reconciling the quest for subjectivity with the question of reliability. Psychological Medicine 1998; 28: 165–172
   PubMed Web of Science ®Google Scholar
• Herrman H, Hawthorne G, Thomas R. Assessment in people living with psychosis. 6th International Society for Quality of Life Research conference, Barcelona. Quality of Life Research. 1999; 8: 662
   Google Scholar
• Murray C, Lopez A. The global burden of disease. World Health Organization, Geneva 1996
   Google Scholar
• Richardson J, Hawthorne G. Difficulty with life and death: methodological issues and results from the utility scaling of the ‘Assessment of Quality of Life’ (AQoL) instrument. Economics and Health 1988, C Baldry. The University of Sydney, School of Health Services Management, Sydney 1998; 121–138
   Google Scholar
• Nord E, Richardson J, Macarounas-Kirchmann K. Social evaluation of health care versus personal evaluation of health states. Evidence on the validity of four health-state scaling instruments using Norwegian and Australian surveys. International Journal of Technology Assessment in Health Care 1993; 9: 463–478
   PubMedGoogle Scholar
• Richardson J, Olsen J, Hawthorne G, Mortimer D, Smith R. The measurement and valuation of utility-based quality of life. Centre for Health Program Evaluation, Melbourne 1999, Working Paper No. 96
   Google Scholar
• Hogan A, Hawthorne G, Taylor A, et al. Quality-of-life outcomes in the adult Cochlear implant program: a cross-sectional study. Cochlear Implants International in press
   Google Scholar
• Hawthorne G, Herrman H, Thomas R. The validity of self-report health-related quality of life among those suffering mental illness. Presented at the American Psychiatric Association's ‘Value of Psychiatry: Economic and Health Policy Implications’ Workshop, May 2000, Chicago. Journal of Mental Health Policy and Economics 2000; 3(Suppl. 1)S10
   Google Scholar
• Williams A. Health and economics. Macmillan, London 1987
   Google Scholar
• Salize H, Rossler W. The cost of comprehensive care of people with schizophrenia living in the community. A cost evaluation from a German catchment area. British Journal of Psychiatry 1996; 169: 42–48
   PubMed Web of Science ®Google Scholar
• Davies L, Drummond M. Assessment of costs and benefits of drug therapy for treatment-resistant schizophrenia in the United Kingdom. British Journal of Psychiatry 1993; 162: 3842
   Web of Science ®Google Scholar
• Deeble J. Resource allocation in public health. National Public Health Partnership, Melbourne 1999
   Google Scholar
• Beevor A, Curtis R. HoNOS: Health of the Nation Outcome Scales Health Questionnaire. Royal College of Psychiatrists Research Unit, London 1995
   Google Scholar
• Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 1960; 23: 56–62
   PubMed Web of Science ®Google Scholar
• World Bank. World development report 1993: investing in health. The World Bank/Oxford University Press, Oxford 1993
   Google Scholar
• Burden of Disease Unit. The health sector in Mauritius: resource use, intervention cost and options for efficiency enhancement. Burden of Disease Unit, Harvard Centre for Population and Development Studies, Cambridge 1997
   Google Scholar
• Vos E, Timaeus I, Huttly S, Murray C, Michaud C. Mauritius health sector reform: national burden of disease study. London School of Hygiene and Tropical Medicine, London University, London 1995
   Google Scholar
• Richardson J. Economic assessment of health care: theory and practice. Australian Economic Review 1991; 1: 4–19
   Google Scholar
• Rutz W, Carlsson P, von-Knorring L, Walinder J. Cost-benefit analysis of an educational program for general practitioners by the Swedish Committee for the Prevention and Treatment of Depression. Acta Psychiatrica Scandinavica 1992; 85: 457–464
   PubMed Web of Science ®Google Scholar
• Drummond M. Cost-effectiveness guidelines for reimbursement of pharmaceuticals: is economic evaluation ready for its enhanced status?. Health Economics 1992; 1: 85–92
   PubMedGoogle Scholar
• Harris A, Crowley S, Defina J, Hawthorne G. Checklist for the design of protocols to collect economic data alongside clinical trials in Australia. Centre for Health Program Evaluation, Melbourne 1996, Working Paper No. 51
   Google Scholar
• Cronbach L. Designing evaluations of educational and social programs. Jossey-Bass, San Francisco 1982
   Google Scholar
• Campbell D. Relabeling internal and external validity for applied social scientists. New Directions for Program Evaluation 1986; 31: 67–77
   Google Scholar
• Murray C, Evans D, Acharya A, Baltussen R. Development of WHO guidelines on generalised cost-effectiveness analysis. World Health Organization, Geneva 1999, Discussion Paper N4
   Google Scholar
• Torrance G. Designing and conducting cost-utility analyses. Quality of life and pharmacoeconomics in clinical trials, B Spilker. Lippincott-Raven, Philadelphia 1996; 1105–1112
   Google Scholar
• Edgar A, Salek S, Shickle D, Cohen D. The ethical QALY: ethical issues in healthcare resource allocation. Euromed Communications, Haslemere 1998
   Google Scholar